Leukotriene B4 receptor type 2 protects against pneumolysin-dependent acute lung injury

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Shigematsu, Misako ^a,b   Koga, Tomoaki ^a   Ishimori, Ayako ^a   Saeki, Kazuko ^a   Ishii, Yumiko ^b   Taketomi, Yoshitaka ^c   Ohba, Mai ^a   Jo Watanabe, Airi ^a   Okuno, Toshiaki ^a   Harada, Norihiro ^a   Harayama, Takeshi ^d,e   Shindou, Hideo ^d   Li, Jian Dong ^f   Murakami, Makoto ^c   Hoka, Sumio ^b   Yokomizo, Takehiko ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^e UNIVERSITY OF GENEVA   (Switzerland)

^f GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; LEUKOTRIENE B4 RECEPTOR; LTB4R2 PROTEIN, MOUSE; PLY PROTEIN, STREPTOCOCCUS PNEUMONIAE; STREPTOLYSIN;

ACUTE LUNG INJURY; ANIMAL; CAPILLARY PERMEABILITY; CHEMICALLY INDUCED; DRUG EFFECT; ENDOTHELIUM CELL; GENETICS; KNOCKOUT MOUSE; MAST CELL; METABOLISM; MOUSE; PATHOLOGY;

ACUTE LUNG INJURY; ANIMALS; BACTERIAL PROTEINS; CAPILLARY PERMEABILITY; ENDOTHELIAL CELLS; MAST CELLS; MICE; MICE, KNOCKOUT; RECEPTORS, LEUKOTRIENE B4; STREPTOLYSINS;

EID: 84990243300     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep34560     Document Type: Article

References (45)

1. Black, R. E., et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 375, 1969-1987, doi: 10.1016/S0140-6736(10)60549-1 (2010
2. Musher, D. M., & Thorner, A. R. Community-acquired pneumonia. N. Engl. J. Med. 371, 1619-1628, doi: 10.1056/NEJMra1312885 (2014
3. Jefferies, S., Weatherall, M., Young, P., Eyers, S., & Beasley, R. Systematic review, and meta-analysis of the effects of antipyretic medications on mortality in Streptococcus pneumoniae infections. Postgrad Med J 88, 21-27, doi: 10.1136/postgradmedj-2011-130217 (2012
4. Hollingshead, S. K., & Briles, D. E. Streptococcus pneumoniae: new tools for an old pathogen. Curr Opin Microbiol 4, 71-77 (2001
5. Brandenburg, J. A., et al. Clinical presentation, processes, and outcomes of care for patients with pneumococcal pneumonia. J Gen Intern Med 15, 638-646 (2000
6. Rossjohn, J., et al. The molecular mechanism of pneumolysin, a virulence factor from Streptococcus pneumoniae. J. Mol. Biol. 284, 449-461, doi: 10.1006/jmbi.1998.2167 (1998
7. Cockeran, R., Anderson, R., & Feldman, C. The role of pneumolysin in the pathogenesis of Streptococcus pneumoniae infection. Curr Opin Infect Dis 15, 235-239 (2002
8. Rubins, J. B., et al. Toxicity of pneumolysin to pulmonary alveolar epithelial cells. Infect. Immun. 61, 1352-1358 (1993
9. Bradley, J. S., et al. The management of community-acquired pneumonia in infants, and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society, and the Infectious Diseases Society of America. Clin Infect Dis 53, e25-e76, doi: 10.1093/cid/cir531 (2011
10. Mandell, L. A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44 Suppl 2, S27-S72, doi: 10.1086/511159 (2007
11. Yokomizo, T., Kato, K., Terawaki, K., Izumi, T., & Shimizu, T. A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation, and immunological disorders. J. Exp. Med. 192, 421-432 (2000
12. Okuno, T., et al. 12(S)-Hydroxyheptadeca-5Z, 8E, 10E-trienoic acid is a natural ligand for leukotriene B4 receptor 2. J. Exp. Med. 205, 759-766, doi: 10.1084/jem.20072329 (2008
13. Liu, M., et al. 12-Hydroxyheptadecatrienoic acid promotes epidermal wound healing by accelerating keratinocyte migration via the BLT2 receptor. J. Exp. Med. 211, 1063-1078, doi: 10.1084/jem.20132063 (2014
14. Iizuka, Y., et al. Protective role of the leukotriene B4 receptor BLT2 in murine inflammatory colitis. FASEB J. 24, 4678-4690, doi: 10.1096/fj.10-165050 (2010
15. Ishii, Y., et al. Leukotriene B4 receptor type 2 (BLT2) enhances skin barrier function by regulating tight junction proteins. FASEB J. in press, doi: 10.1096/fj.1015-279653 (2015
16. Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., & Shimizu, T. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 387, 620-624, doi: 10.1038/42506 (1997
17. Iizuka, Y., et al. Characterization of a mouse second leukotriene B4 receptor, mBLT2: BLT2-dependent ERK activation, and cell migration of primary mouse keratinocytes. J. Biol. Chem. 280, 24816-24823, doi: 10.1074/jbc.M413257200 (2005
18. Harayama, T., et al. Lysophospholipid acyltransferases mediate phosphatidylcholine diversification to achieve the physical properties required in vivo. Cell Metab. 20, 295-305, doi: 10.1016/j.cmet.2014.05.019 (2014
19. Witzenrath, M., et al. Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia. Crit. Care. Med. 34, 1947-1954, doi: 10.1097/01.CCM.0000220496.48295.A9 (2006
20. Weiss, J. W., et al. Bronchoconstrictor effects of leukotriene C in humans. Science 216, 196-198 (1982
21. Matsunobu, T., Okuno, T., Yokoyama, C., & Yokomizo, T. Thromboxane A synthase-independent production of 12-hydroxyheptadecatrienoic acid, a BLT2 ligand. J. Lipid. Res. 54, 2979-2987, doi: 10.1194/jlr.M037754 (2013
22. Kanaoka, Y., Maekawa, A., & Austen, K. F. Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand. J. Biol. Chem. 288, 10967-10972, doi: 10.1074/jbc.C113.453704 (2013
23. Austen, K. F., Maekawa, A., Kanaoka, Y., & Boyce, J. A. The leukotriene E4 puzzle: finding the missing pieces, and revealing the pathobiologic implications. J. Allergy Clin. Immunol. 124, 406-414; quiz 415-406, doi: 10.1016/j.jaci.2009.05.046 (2009
24. Cho, K. J., Seo, J. M., Lee, M. G., & Kim, J. H. BLT2 Is upregulated in allergen-stimulated mast cells, and mediates the synthesis of Th2 cytokines. J. Immunol. 185, 6329-6337, doi: 10.4049/jimmunol.1001213 (2010
25. Taketomi, Y., et al. Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis. Nat. Immunol. 14, 554-563, doi: 10.1038/ni.2586 (2013
26. Holgate, S. T., & Polosa, R. Treatment strategies for allergy, and asthma. Nat. Rev. Immunol. 8, 218-230, doi: 10.1038/nri2262 (2008
27. Peters-Golden, M., & Henderson, W. R., Jr. Leukotrienes. N. Engl. J. Med. 357, 1841-1854, doi: 10.1056/NEJMra071371 (2007
28. Lynch, K. R., et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399, 789-793, doi: 10.1038/21658 (1999
29. Messika, J., et al. Risks of nonsteroidal antiinflammatory drugs in undiagnosed intensive care unit pneumococcal pneumonia: younger, and more severely affected patients. J. Crit. Care. 29, 733-738, doi: 10.1016/j.jcrc.2014.05.021 (2014
30. Voiriot, G., Dury, S., Parrot, A., Mayaud, C., & Fartoukh, M. Nonsteroidal antiinflammatory drugs may affect the presentation, and course of community-acquired pneumonia. Chest 139, 387-394, doi: 10.1378/chest.09-3102 (2011
31. Esposito, A. L. Aspirin impairs antibacterial mechanisms in experimental pneumococcal pneumonia. Am. Rev. Respir. Dis. 130, 857-862 (1984
32. Maekawa, A., Xing, W., Austen, K. F., & Kanaoka, Y. GPR17 regulates immune pulmonary inflammation induced by house dust mites. J. Immunol. 185, 1846-1854, doi: 10.4049/jimmunol.1001131 (2010
33. Maekawa, A., Balestrieri, B., Austen, K. F., & Kanaoka, Y. GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4. Proc Natl Acad Sci USA 106, 11685-11690, doi: 10.1073/pnas.0905364106 (2009
34. Jiang, Y., Borrelli, L. A., Kanaoka, Y., Bacskai, B. J., & Boyce, J. A. CysLT2 receptors interact with CysLT1 receptors, and downmodulate cysteinyl leukotriene dependent mitogenic responses of mast cells. Blood 110, 3263-3270, doi: 10.1182/blood-2007-07-100453 (2007
35. Levy, B. D., & Serhan, C. N. Resolution of acute inflammation in the lung. Annu. Rev. Physiol. 76, 467-492, doi: 10.1146/annurevphysiol-021113-170408 (2014
36. Abdulnour, R. E., et al. Maresin 1 biosynthesis during platelet-neutrophil interactions is organ-protective. Proc Natl Acad Sci USA 111, 16526-16531, doi: 10.1073/pnas.1407123111 (2014
37. Terawaki, K., et al. Absence of leukotriene B4 receptor 1 confers resistance to airway hyperresponsiveness, and Th2-type immune responses. J. Immunol. 175, 4217-4225 (2005
38. Lim, J. H., et al. Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections. Immunity 27, 349-360, doi: 10.1016/j.immuni.2007.07.011 (2007
39. Hamaguchi, M., et al. Loxoprofen Sodium, a Non-Selective NSAID, Reduces Atherosclerosis in Mice by Reducing Inflammation. J Clin Biochem Nutr 47, 138-147, doi: 10.3164/jcbn.10-33 (2010
40. Eum, S. Y., et al. Involvement of the cysteinyl-leukotrienes in allergen-induced airway eosinophilia, and hyperresponsiveness in the mouse. Am. J. Respir. Cell Mol. Biol. 28, 25-32, doi: 10.1165/rcmb.4532 (2003
41. Standiford, T. J., et al. Macrophage inflammatory protein-1 alpha mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. J. Immunol. 155, 1515-1524 (1995
42. Green, T. P., Johnson, D. E., Marchessault, R. P., & Gatto, C. W. Transvascular flux, and tissue accrual of Evans blue: effects of endotoxin, and histamine. J. Lab. Clin. Med. 111, 173-183 (1988
43. Corti, M., Brody, A. R., & Harrison, J. H. Isolation, and primary culture of murine alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 14, 309-315, doi: 10.1165/ajrcmb.14.4.8600933 (1996
44. Sobczak, M., Dargatz, J., & Chrzanowska-Wodnicka, M. Isolation, and culture of pulmonary endothelial cells from neonatal mice. J Vis Exp, doi: 10.3791/2316 (2010
45. Dewi, B. E., Takasaki, T., & Kurane, I. In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines, and dengue virus infection. J Virol Methods 121, 171-180, doi: 10.1016/j.jviromet.2004.06.013 (2004